Effect of Lemborexant on Sleep Architecture in Adult and Elderly Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease

被引：0
|
作者：
Zammit, Gary [1 ]
Cheng, Jocelyn [1 ]
Hall, Nancy [1 ]
Moline, Margaret [1 ]
机构：
[1] Eisai Inc, Nutley, NJ USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Dual Orexin Receptor Antagonists; COPD; Sleep Architecture; Insomnia;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P581
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [31] Effect of Exercise Training in Patients With Chronic Obstructive Pulmonary Disease Compared With Healthy Elderly Subjects
    Mador, M. Jeffery
    Krauza, Matthew
    Shaffer, Mary
    JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION, 2012, 32 (03) : 155 - 162
  • [32] Sleep disturbance in patients with mild-moderate chronic obstructive pulmonary disease
    Lee, Sang Hee
    Kim, Ki Uk
    Lee, Haejung
    Park, Hye-Kyung
    Kim, Yun Seong
    Lee, Min Ki
    CLINICAL RESPIRATORY JOURNAL, 2019, 13 (12): : 751 - 757
  • [33] Predicting Oxygen Uptake for Men with Moderate to Severe Chronic Obstructive Pulmonary Disease
    Kim, Changhwan
    Park, Yong Bum
    Mo, Eun Kyung
    Choi, Eun Hee
    Nam, Hee Seung
    Lee, Sung-Soon
    Yoo, Young Won
    Yang, Yun Jun
    Moon, Joung Wha
    Kim, Dong Soon
    Lee, Hyang Yi
    Jin, Young Soo
    Lee, Hye Young
    Chun, Eun Mi
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2008, 64 (06) : 433 - 438
  • [34] Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease
    Nannini, LJ
    Flores, DM
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2003, 16 (05) : 307 - 311
  • [35] BURDEN OF ILLNESS ASSOCIATED WITH MODERATE TO VERY SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Singh, M.
    Baculea, S.
    Quigley, J. M.
    Bergstrom, G.
    Holmgren, U.
    VALUE IN HEALTH, 2016, 19 (03) : A118 - A119
  • [36] Treatment options for moderate-to-very severe chronic obstructive pulmonary disease
    Cazzola, Mario
    Rogliani, Paola
    Ora, Josuel
    Matera, Maria Gabriella
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 977 - 988
  • [37] The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada
    Maleki-Yazdi, M. Reza
    Kelly, Suzanne M.
    Lam, Sy S.
    Marin, Mihaela
    Barbeau, Martin
    Walker, Valery
    CANADIAN RESPIRATORY JOURNAL, 2012, 19 (05) : 319 - 324
  • [38] Safety of sputum induction in moderate-to-severe chronic obstructive pulmonary disease
    Sutherland, ER
    Pak, J
    Langmack, EL
    Silkoff, PE
    Martin, RJ
    RESPIRATORY MEDICINE, 2002, 96 (07) : 482 - 486
  • [39] Inflammatory Markers and Fatigue in Individuals With Moderate to Severe Chronic Obstructive Pulmonary Disease
    Lee, Jung Eun
    Nguyen, Huong Q.
    Fan, Vincent S.
    NURSING RESEARCH, 2024, 73 (01) : 54 - 61
  • [40] Should we avoid β-agonists for moderate and severe chronic obstructive pulmonary disease?
    Salpeter, Shelley R.
    Aaron, Shawn D.
    CANADIAN FAMILY PHYSICIAN, 2007, 53 : 1290 - 1293
12345